- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02631291
Promoting Widowed Elders Lifestyle After Loss
March 26, 2020 updated by: Sarah T. Stahl, PhD, University of Pittsburgh
A Randomized Pilot Study of Behavioral Self-monitoring to Promote Mental Health Among Spousally Bereaved Older Adults
This study is for adults 60 years and older who are grieving the recent loss of a spouse or partner.
Bereavement is one of the most distressing transitions faced by older adults and triggers dramatic changes to older adults' daily routine which puts them at-risk for a mood disorder.
The purpose of this study is to promote bereaved elders' mental health by focusing on healthy lifestyle practices.
Study treatment involves using a tablet to record their daily physical activity, diet, and sleep behaviors, for 12 weeks.
The investigators follow-up with people for up to one year.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Preventing mental health problems that develop following spousal bereavement is important because these conditions are highly prevalent and have lasting adverse consequences for the well-being of the bereaved survivor.
The proposed research will evaluate the feasibility and acceptability of a healthy lifestyle intervention that uses a technology-based behavioral self-monitoring protocol to encourage engagement in physical activity, healthy eating, and good sleep practices following spousal bereavement.
Data from 10 participants will be used for the development of a prevention intervention manual (Aim 1).
A small pilot study will be conducted (Aim 2) in which 50 participants will be randomly assigned to 12 weeks of (1) behavioral self-monitoring using a smartphone (n=20), (2) behavioral self-monitoring using a smartphone + motivational interviewing-based lifestyle coaching (n=20), or (3) enhanced usual care (n=10).
Blood samples will be collected to explore inflammatory cytokines as a potential mediator/moderator of mental health risk.
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Sarah Stahl
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 60 years and older
- experiencing the recent death (within 8 months) of a spouse or partner
- at-risk for developing mental health problems, based on high-risk markers defined as: subthreshold symptoms of depression (Hamilton Depression Rating Scale [HAM-D]101 of 9-14), anxiety (Generalized Anxiety Disorder Scale [GAD-7] ≥ 10, and/or complicated grief (Inventory of Complicated Grief [ICG] of 20-29), together with absence of current major depression, generalized anxiety, post-traumatic stress, or suicidiality; or high medical comorbidity (2 or more systems on the CIRS-G), low social support (Perceived Isolation Scale below zero), functional disability (limitation with at least 1 ADL/IADL),or
Exclusion Criteria:
- current DSM-V criteria for syndromal mood, psychosis, anxiety, eating disorder, or substance abuse dependence;
- dementia; 3MS<80;
- patients taking psychotropic medications to stabilize mental health problems including antidepressants and benzodiazepines;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Lifestyle
Behavioral self-monitoring of daily physical activity, dietary, and sleep behaviors, for 12 weeks, into an electronic tablet.
|
Behavioral self-monitoring will teach older adults to pay attention to their daily lifestyle practices and the conditions in which they occur.
Behavioral self-monitoring is crucial for detecting change early, thereby preventing complications (mental illness symptom burden) that are associated with disruptions in healthy lifestyle practices.
The steps of behavioral self-monitoring include: (1) selecting a goal, (2) paying attention to some aspect of behavior, and (3) recording some details of that behavior in a diary.
|
|
No Intervention: Usual Care
Participants randomized to this condition will receive the written education provided to all participants.
|
|
|
Experimental: LIfestyle + coaching
Behavioral self-monitoring of daily physical activity, dietary, and sleep behaviors, for 12 weeks, into an electronic tablet; and behavioral self-monitoring + motivational interviewing lifestyle coaching.
|
Participants will receive the same Behavioral self-monitoring intervention; participants in this condition will interact with a 'lifestyle coach' about their recorded behaviors, weekly.
The lifestyle coach will use motivational interviewing to enhance older adults' confidence and intrinsic motivation to engage in healthy lifestyle practices.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive symptoms (Hamilton Rating Scale of Depression [HRSD])
Time Frame: 12 months
|
Symptom levels of depression (Hamilton Rating Scale of Depression [HRSD]),
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety symptoms (7-item Generalized Anxiety Disorder Scale [GAD-7])
Time Frame: 12 months
|
Symptom levels of anxiety (7-item Generalized Anxiety Disorder Scale [GAD-7])
|
12 months
|
|
Grief symptoms (Inventory of Complicated Grief [ICG])
Time Frame: 12 months
|
Symptom levels of complicated grief (Inventory of Complicated Grief [ICG])
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sarah Stahl, PhD, University of Pittsburgh
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2015
Primary Completion (Actual)
May 17, 2019
Study Completion (Actual)
May 17, 2019
Study Registration Dates
First Submitted
December 7, 2015
First Submitted That Met QC Criteria
December 15, 2015
First Posted (Estimate)
December 16, 2015
Study Record Updates
Last Update Posted (Actual)
March 30, 2020
Last Update Submitted That Met QC Criteria
March 26, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO14110233
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.